Translating evidence into policy in low-income countries: Lessons from co-trimoxazole preventive therapy;Traduire les preuves en politique dans les pays à faible revenu: Leçons tirées de la thérapie préventive au cotrimoxazole

Bulletin of the World Health Organization

Volumn 89, Issue 4, 2011, Pages 312-316

  Hutchinson, Eleanor ^a   Droti, Benson ^b   Gibb, Diana ^c   Chishinga, Nathaniel ^d   Hoskins, Susan ^c   Phiri, Sam ^e   Parkhurst, Justin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d ZAMBART (Zambia AIDS Related TB) Project   (Zambia)

^e LIGHTHOUSE TRUST   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ISONIAZID;

DEVELOPING WORLD; DISEASE CONTROL; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; LOW INCOME POPULATION; POLICY ANALYSIS; POLICY DEVELOPMENT; POLICY IMPLEMENTATION;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHEMOPROPHYLAXIS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LOWEST INCOME GROUP; OPPORTUNISTIC INFECTION; PREVENTIVE MEDICINE; TRANSLATIONAL RESEARCH; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MALAWI; POVERTY; PRIMARY PREVENTION; SOCIOECONOMIC FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS, PULMONARY; UGANDA; ZAMBIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79955388803     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.10.077743     Document Type: Article

References (20)

1. Zachariah R, Harries AD, Luo C, Bachman G, Graham SM. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis 2007;7:686-93. doi:10.1016/S1473-3099(07)70239-6 PMID:17897611
2. Anglaret X, Eholie S. Cotrimoxazole for HIV infected adults reduces mortality even where bacterial resistance is high. BMJ 2008;337:184.
3. Date AA, Vitoria M, Granich R, Banda M, Fox MY, Gilks C. Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull World Health Organ 2010;88:253-9. doi:10.2471/BLT.09.066522 PMID:20431788
4. Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P etal.; Cotrimo-CI Study Group. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999;353:1463-8. doi:10.1016/S0140-6736(98)07399-1 PMID:10232311
5. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet 1999;353:1469-75. doi:10.1016/S0140-6736(99)03465-0 PMID:10232312
6. Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, Hargreaves NJ et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003;17:1053-61. doi:10.1097/00002030-200305020-00015 PMID:12700456
7. Mwaungulu FBD, Floyd S, Crampin AC, Kasimba S, Malema S, Kanyongoloka H etal. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ 2004;82:354-63. PMID:15298226
8. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004;364:1428-34. doi:10.1016/S0140-6736(04)17225-5 PMID:15488218
9. Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A etal. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Lancet 2010;375:1278-86. doi:10.1016/S0140-6736(10)60057-8 PMID:20347483
10. Wilkinson D. Drugs for preventing tuberculosis in HIV infected persons. Cochrane Database Syst Rev 2000;4:CD000171. PMID:11034676
11. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004;1:CD000171. PMID:14973947
12. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010;1:CD000171. PMID:20091503
13. Joint WHO/UNAIDS/UNICEF statement on the use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children. Geneva: World Health Organization & United Nations Children's Fund; 2004. Available from: http://www.who.int/3by5/mediacentre/en/Cotrimstatement.pdf [accessed 17 February 2011].
14. World Health Organization; UNAIDS. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci 2001;1:30-1. PMID:12833907
15. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: recommendations for a public health approach. Geneva: World Health Organization; 2006.
16. Policy statement on preventive therapy against tuberculosis in people living with HIV. Geneva: World Health Organization; 1998. Available from: http://whqlibdoc.who.int/hq/1998/WHO_TB_98.255.pdf [accessed 17 February 2011].
17. Isoniazid preventive therapy (IPT) for people living with HIV: consensus statement of the core group of TB/HIV Working Group of STOP TB partnership. Geneva: Stop TB partnership; 2007. Available from: http://www.stoptb.org/wg/tb_hiv/assets/documents/IPT%20Consensus%20State ment%20TB%20HIV%20Core%20Group.pdf [accessed 17 February 2011].
18. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva: World Health Organization; 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf [accessed 17 February 2011].
19. Crewe E, Young J. Bridging research and policy: context, evidence and links (Working Paper 173). London: Overseas Development Institute; 2002.
20. Court J, Young J. Bridging research and policy: insights from 50 case studies (Working Paper 213). London: Overseas Development Institute; 2003.